Developer docs
API playgroundTry for free, no card

Search company profiles

RxCap

Full company profile

uuid00027kn

Namestring
RxCap
Legal namestring
RxCap, Inc.
Websiteurl
rxcap.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

RxCap, Inc. is a Boston-based, privately held medication adherence technology company founded in 2015 that builds proprietary cellular-connected hardware (smart caps that replace standard prescription vial closures, an LTE-based smart weekly pill organizer co-developed with Centor, and a smart multidose packaging device that detects pouch removals and bridges to Bluetooth physiological devices) combined with a cloud software platform, a patient portal, a consumer mobile app (RxCap Adhere), and an open API library for healthcare enterprise integration. The company's core technology differentiator is automatic LTE data transmission that requires no patient-side app pairing or setup, capturing real-time, event-level medication consumption rather than relying on retrospective metrics such as Proportion of Days Covered (PDC). RxCap is certified in the Epic App Orchard, enabling clinicians to launch adherence programs and view real-time data inside the Epic EMR at the point of care, and integrates with OMRON Connect 2.0, FDB Meducation, ZEPHYRx cloud spirometry, and Wysa's behavioral health platform.

RxCap serves four primary customer segments: (1) pharmacies and providers seeking reimbursable Remote Therapeutic Monitoring (RTM) and Remote Patient Monitoring (RPM) programs under CMS CPT codes 98975–98981; (2) health plans and PBMs pursuing improved STAR ratings and reduced hospitalization costs; (3) device manufacturers seeking differentiated connected product offerings; and (4) life sciences companies for clinical trial adherence and post-commercialization patient support. Named enterprise relationships include Yale Medical, UCLA (clinical study NCT03460587 reporting 90.9% adherence in stroke survivors), OMRON Healthcare, First Databank, ZEPHYRx, Medistics, and Wysa.

The business model combines hardware sales (smart caps, pill organizers, multidose packaging), recurring software and API platform subscriptions (including white-label arrangements), exclusive channel distribution through Centor/Gerresheimer for U.S. pharmacies, and customized managed services for enterprise partners. In April 2024, Gerresheimer acquired a minority equity stake in RxCap and secured exclusive U.S. pharmacy distribution rights through its subsidiary Centor, while appointing a director to RxCap's board—signaling strategic validation and a major channel unlock. As of 2024, RxCap had raised approximately $21.16 million across roughly 22 investors via an SEC Form D exempt offering.

Short descriptiontext

RxCap is a Boston-based medication adherence technology company providing LTE-connected smart caps, pill organizers, and multidose packaging devices, plus cloud software and APIs, for U.S. pharmacies, health plans, device manufacturers, and life sciences companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medication adherence monitoring, cellular smart caps, remote therapeutic monitoring, remote patient monitoring, digital health adherence devices
Industry4 codes
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAKAF
Medication Adherence, Reminders & Patient Support
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAFAJ
Patient App, Adherence & Engagement for RPM Programs
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAEAKAH
Medication Therapy Management (MTM) & Adherence Programs
NAICS code1 code
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Prepackaged Software7372
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medication Adherence Devices
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Connected Device Sales
TypeHardware Sales
Description

Sale of proprietary cellular medication adherence devices including smart caps, pill organizers, and multidose packaging devices. Devices can be white-labeled for partners.

rxcap.com
2Software Platform and API Access
TypeSubscription Recurring
Description

Cloud-based software platform for data collection, monitoring, and patient engagement. API access for enterprise integration. Supports reimbursable Remote Therapeutic Monitoring (RTM) services.

rxcap.com
3Channel Distribution (Centor/Gerresheimer)
TypeLicensing Royalties
Description

Exclusive distribution partnership for U.S. pharmacies through Centor. RxCap provides devices and software, Centor handles pharmacy sales and customer relationships.

rxcap.com
4Strategic Partnership Solutions
TypeManaged Services
Description

Customized solutions for enterprise partners including device customization, white-labeling, and integrated remote monitoring programs.

rxcap.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1RxCap Adhere
Description

Patient-facing mobile app for medication adherence tracking with FDB Meducation integration

rxcap.com
Core offering1 text field

RxCap designs, manufactures, and sells proprietary cellular LTE-connected medication adherence hardware (smart caps, weekly pill organizers, and multidose packaging devices) and pairs them with cloud-based software, patient-facing portal and mobile apps, and an API library. The platform enables healthcare enterprises to capture real-time medication adherence events and run reimbursable Remote Therapeutic Monitoring (RTM) and Remote Patient Monitoring (RPM) programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 90.9% prescription adherence rate observed in clinical study of stroke survivors using RxCap technology
+2 more records
Product overview1 text field

RxCap is a medication adherence partner offering a modular portfolio of software, APIs, and devices for healthcare enterprises. The product portfolio consists of proprietary adherence monitoring hardware (Cellular Smart Caps, Smart Pill Organizer, Smart Multidose Packaging Device, and Proprietary Data Hubs) combined with patient-facing software (Patient Portal, Mobile Apps including RxCap Adhere) and an API Library for developer integration. The platform enables real-time medication adherence monitoring with cellular devices that transmit data automatically without patient setup, supporting remote therapeutic monitoring and remote patient monitoring programs for pharmacies, health plans, device manufacturers, and life sciences companies.

Product and service6 records
1Cellular Smart Caps
CategoryMedication Adherence Hardware
Description

Smart caps that attach to standard prescription vials and automatically record and transmit medication adherence data via cellular LTE signals when the vial is opened, designed for healthcare enterprises running remote monitoring and adherence programs.

2Smart Pill Organizer
CategoryMedication Adherence Hardware
Description

LTE-based weekly pill organizer with LED indicators that automatically captures and transmits real-time medication removal events without requiring patient app installation, available to U.S. pharmacies via Centor (Gerresheimer).

3Smart Multidose Packaging Device
CategoryMedication Adherence Hardware
Description

Cellular-connected device that automatically tracks when medication pouches are removed from the box and supports all common multidose pouch and sleeve sizes, with optional Bluetooth pairing of physiological devices for additional clinical insight.

4Proprietary Data Hubs
CategoryRemote Monitoring Hardware
Description

Proprietary data collection and transmission hubs that provide secure, zero-friction remote monitoring across RxCap's adherence and integrated physiological devices for healthcare enterprises.

5RxCap Adhere Mobile App
CategoryPatient Engagement Software
Description

Patient-facing mobile app that lets patients import prescribed medications, receive medication reminders, record adherence confirmations, access simplified Meducation instructions, and alert caregivers when doses are missed.

6RxCap API Library
CategoryIntegration and Developer APIs
Description

Open-architecture API library that enables healthcare enterprises and ecosystem partners to integrate RxCap's adherence and physiological data into their own care management platforms, EHR workflows, and remote monitoring services.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-06-24
Description

Wysa, a global leader in AI-driven behavioral health support, announced a strategic partnership with RxCap to bring remote monitoring technology into Wysa's care platform. Through this integration, Wysa's healthcare clients can deploy RxCap's connected adherence devices and cloud-based software directly within their existing care workflows. The collaboration gives provider clients real-time insights into medication adherence to help drive better patient outcomes and more effective care management.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-04-23
Description

Centor Inc., a Gerresheimer company and leading provider of regulatory compliant prescription containers and remote care solutions, co-developed a new LTE-based smart weekly pill organizer with RxCap. The smart pill organizer is now available to U.S. pharmacies through Centor's remote monitoring service. This partnership solidifies Centor's position as a leader in innovative drug containment and medication adherence solutions.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-04-29
Description

Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, partnered with RxCap and acquired a minority stake. Under the terms of the agreement, Gerresheimer's subsidiary Centor receives the exclusive distribution rights for pharmacies in the U.S. for adherence solutions by RxCap, consisting of connected prescription vial closure devices and complementary cloud-based software. Centor is the U.S. market leader in prescription vials and is uniquely positioned to enable smart adherence solutions through existing pharmacy workflows. Gerresheimer will also appoint a representative to RxCap's Board of Directors.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-09-19
Description

RxCap partnered with ZEPHYRx LLC, a remote respiratory monitoring solutions provider, to integrate the ZEPHYRx cloud spirometry platform with RxCap's remote monitoring platform. With this partnership, RxCap's enterprise customers can monitor the lung function of their patients with serious pulmonary conditions. The combination enables medication adherence data from RxCap's devices combined with real-time pulmonary function test data from ZEPHYRx to improve patient outcomes.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-01
Description

Medistics LLC, a New Jersey-based care management company, partnered with RxCap to provide a comprehensive Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) solution. The partnership enables Qualified Health Care Professionals (QHCPs) to offer reimbursable services by utilizing existing RPM/RTM programs for their patients, providing more personalized and proactive care.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-05-04
Description

RxCap achieved certification and availability of their prescription adherence platform within the Epic App Orchard. The integration enables doctors and clinicians to access real-time medication adherence data directly within Epic EMR workflows at the point of care, within seconds. Clinicians can also access additional medication handling information like humidity and temperature data through RxCap's portal directly integrated with Epic.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2020-10-20
Description

First Databank (FDB), the leading provider of drug and medical device knowledge, partnered with RxCap to release a patient-facing mobile app (RxCap Adhere) that allows patients to import personalized medication instructions from FDB Meducation. The app includes medication reminders, adherence confirmation, and access to educational materials written at 5th- to 8th-grade reading level.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2020-01-06
Description

OMRON Healthcare partnered with RxCap to integrate smart medication caps with OMRON Connect 2.0 digital health service. Through the partnership, OMRON Connect 2.0 pairs with RxCap smart medication caps to monitor adherence and set reminders to take specific medications, fostering patient-doctor dialogue and providing personalized insights.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1AdhereTech
TypeDirect peer
Description

AdhereTech makes connected smart pill bottles that automatically track medication adherence and send real-time reminders, directly overlapping with RxCap's smart cap and adherence device portfolio for pharma and health system customers.

TypeDirect peer
Description

Medisafe is a digital medication adherence platform combining a patient app, reminders, and analytics for pharma and health plans — directly comparable to RxCap's patient-facing app and adherence analytics stack.

TypeDirect peer
Description

eTectRx produces the ID-Cap system, a smart cap with embedded ingestible event marker that confirms actual medication ingestion — a close technical peer to RxCap's smart cap adherence technology.

TypeDirect peer
Description

MedMinder provides connected pill dispensers with cellular connectivity and adherence reminders for pharmacies, patients, and caregivers — competing in the same pharmacy-channel smart adherence category as RxCap.

TypeDirect peer
Description

Spencer Health Solutions offers a connected medication dispensing and adherence platform with integrated RPM, serving pharma, payers, and providers with a comparable hardware-plus-software model to RxCap.

TypeDirect peer
Description

Hero Health makes a smart pill dispenser with reminders and adherence tracking, competing in the connected medication management space where RxCap's smart pill organizer and multidose devices operate.

TypeEmerging player
Description

Propeller Health provides connected inhaler sensors and respiratory adherence platforms, overlapping with RxCap's adherence + physiological device integration strategy in chronic respiratory care.

TypeBroad incumbent
Description

Vivify Health is an established RPM/RTM platform serving health systems and payers with broader remote care workflows, competing with RxCap on the enterprise RTM billing side.

9Health Recovery Solutions (HRS)
TypeBroad incumbent
Description

HRS provides RPM kits, software, and clinical workflow tools for hospitals and home health agencies, offering a broader RPM alternative to RxCap's adherence-focused platform.

TypeBroad incumbent
Description

Caregility is a broader virtual care and RPM platform serving health systems, with adjacent adherence and remote monitoring capabilities that overlap RxCap's enterprise RPM/RTM positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RxCap

Medication Adherence Devicesrxcap.com

RxCap is a Boston-based medication adherence technology company providing LTE-connected smart caps, pill organizers, and multidose packaging devices, plus cloud software and APIs, for U.S. pharmacies, health plans, device manufacturers, and life sciences companies.

What RxCap does

RxCap, Inc. is a Boston-based, privately held medication adherence technology company founded in 2015 that builds proprietary cellular-connected hardware (smart caps that replace standard prescription vial closures, an LTE-based smart weekly pill organizer co-developed with Centor, and a smart multidose packaging device that detects pouch removals and bridges to Bluetooth physiological devices) combined with a cloud software platform, a patient portal, a consumer mobile app (RxCap Adhere), and an open API library for healthcare enterprise integration. The company's core technology differentiator is automatic LTE data transmission that requires no patient-side app pairing or setup, capturing real-time, event-level medication consumption rather than relying on retrospective metrics such as Proportion of Days Covered (PDC). RxCap is certified in the Epic App Orchard, enabling clinicians to launch adherence programs and view real-time data inside the Epic EMR at the point of care, and integrates with OMRON Connect 2.0, FDB Meducation, ZEPHYRx cloud spirometry, and Wysa's behavioral health platform.

RxCap serves four primary customer segments: (1) pharmacies and providers seeking reimbursable Remote Therapeutic Monitoring (RTM) and Remote Patient Monitoring (RPM) programs under CMS CPT codes 98975–98981; (2) health plans and PBMs pursuing improved STAR ratings and reduced hospitalization costs; (3) device manufacturers seeking differentiated connected product offerings; and (4) life sciences companies for clinical trial adherence and post-commercialization patient support. Named enterprise relationships include Yale Medical, UCLA (clinical study NCT03460587 reporting 90.9% adherence in stroke survivors), OMRON Healthcare, First Databank, ZEPHYRx, Medistics, and Wysa.

The business model combines hardware sales (smart caps, pill organizers, multidose packaging), recurring software and API platform subscriptions (including white-label arrangements), exclusive channel distribution through Centor/Gerresheimer for U.S. pharmacies, and customized managed services for enterprise partners. In April 2024, Gerresheimer acquired a minority equity stake in RxCap and secured exclusive U.S. pharmacy distribution rights through its subsidiary Centor, while appointing a director to RxCap's board—signaling strategic validation and a major channel unlock. As of 2024, RxCap had raised approximately $21.16 million across roughly 22 investors via an SEC Form D exempt offering.

RxCap firmographics

Firmographics
Name
RxCap
Legal name
RxCap, Inc.
Website
https://rxcap.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
RxCap is a Boston-based medication adherence technology company providing LTE-connected smart caps, pill organizers, and multidose packaging devices, plus cloud software and APIs, for U.S. pharmacies, health plans, device manufacturers, and life sciences companies.
Ownership category
akta.pro rank

RxCap industry classification

Industry
Product category
Medication Adherence Devices
NAICS
Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAKAF
Medication Adherence, Reminders & Patient Support
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAFAJ
Patient App, Adherence & Engagement for RPM Programs
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAEAKAH
Medication Therapy Management (MTM) & Adherence Programs

Keywords

  • Medication adherence monitoring
  • Cellular smart caps
  • Remote therapeutic monitoring
  • Remote patient monitoring
  • Digital health adherence devices

Where RxCap is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

RxCap business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Connected Device Sales: Sale of proprietary cellular medication adherence devices including smart caps, pill organizers, and multidose packaging devices. Devices can be white-labeled for partners.
  2. Software Platform and API Access: Cloud-based software platform for data collection, monitoring, and patient engagement. API access for enterprise integration. Supports reimbursable Remote Therapeutic Monitoring (RTM) services.
  3. Channel Distribution (Centor/Gerresheimer): Exclusive distribution partnership for U.S. pharmacies through Centor. RxCap provides devices and software, Centor handles pharmacy sales and customer relationships.
  4. Strategic Partnership Solutions: Customized solutions for enterprise partners including device customization, white-labeling, and integrated remote monitoring programs.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

RxCap product offering

Product offering

Core offering

RxCap designs, manufactures, and sells proprietary cellular LTE-connected medication adherence hardware (smart caps, weekly pill organizers, and multidose packaging devices) and pairs them with cloud-based software, patient-facing portal and mobile apps, and an API library. The platform enables healthcare enterprises to capture real-time medication adherence events and run reimbursable Remote Therapeutic Monitoring (RTM) and Remote Patient Monitoring (RPM) programs.

Product overview

RxCap is a medication adherence partner offering a modular portfolio of software, APIs, and devices for healthcare enterprises. The product portfolio consists of proprietary adherence monitoring hardware (Cellular Smart Caps, Smart Pill Organizer, Smart Multidose Packaging Device, and Proprietary Data Hubs) combined with patient-facing software (Patient Portal, Mobile Apps including RxCap Adhere) and an API Library for developer integration. The platform enables real-time medication adherence monitoring with cellular devices that transmit data automatically without patient setup, supporting remote therapeutic monitoring and remote patient monitoring programs for pharmacies, health plans, device manufacturers, and life sciences companies.

Differentiator

Problem solved

Functional benefit

Brands

  • RxCap Adhere: Patient-facing mobile app for medication adherence tracking with FDB Meducation integration

Products and services

  • Cellular Smart Caps Smart caps that attach to standard prescription vials and automatically record and transmit medication adherence data via cellular LTE signals when the vial is opened, designed for healthcare enterprises running remote monitoring and adherence programs.
  • Smart Pill Organizer LTE-based weekly pill organizer with LED indicators that automatically captures and transmits real-time medication removal events without requiring patient app installation, available to U.S. pharmacies via Centor (Gerresheimer).
  • Smart Multidose Packaging Device Cellular-connected device that automatically tracks when medication pouches are removed from the box and supports all common multidose pouch and sleeve sizes, with optional Bluetooth pairing of physiological devices for additional clinical insight.
  • Proprietary Data Hubs Proprietary data collection and transmission hubs that provide secure, zero-friction remote monitoring across RxCap's adherence and integrated physiological devices for healthcare enterprises.
  • RxCap Adhere Mobile App Patient-facing mobile app that lets patients import prescribed medications, receive medication reminders, record adherence confirmations, access simplified Meducation instructions, and alert caregivers when doses are missed.
  • RxCap API Library Open-architecture API library that enables healthcare enterprises and ecosystem partners to integrate RxCap's adherence and physiological data into their own care management platforms, EHR workflows, and remote monitoring services.

Quantifiable outcome

  • 90.9% prescription adherence rate observed in clinical study of stroke survivors using RxCap technology
  • +2 more outcomes

Companies that use RxCap

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

RxCap technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability3 records

Feature7 records

RxCap partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and flagship.

  • WysacoreTechnology or Integration · 24 June 2025Wysa, a global leader in AI-driven behavioral health support, announced a strategic partnership with RxCap to bring remote monitoring technology into Wysa's care platform. Through this integration, Wysa's healthcare clients can deploy RxCap's connected adherence devices and cloud-based software directly within their existing care workflows. The collaboration gives provider clients real-time insights into medication adherence to help drive better patient outcomes and more effective care management.
  • Centor (Gerresheimer)flagshipChannel Partner/ Reseller/ Distributor · 23 April 2025Centor Inc., a Gerresheimer company and leading provider of regulatory compliant prescription containers and remote care solutions, co-developed a new LTE-based smart weekly pill organizer with RxCap. The smart pill organizer is now available to U.S. pharmacies through Centor's remote monitoring service. This partnership solidifies Centor's position as a leader in innovative drug containment and medication adherence solutions.
  • Gerresheimer / CentorflagshipChannel Partner/ Reseller/ Distributor · 29 April 2024Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, partnered with RxCap and acquired a minority stake. Under the terms of the agreement, Gerresheimer's subsidiary Centor receives the exclusive distribution rights for pharmacies in the U.S. for adherence solutions by RxCap, consisting of connected prescription vial closure devices and complementary cloud-based software. Centor is the U.S. market leader in prescription vials and is uniquely positioned to enable smart adherence solutions through existing pharmacy workflows. Gerresheimer will also appoint a representative to RxCap's Board of Directors.
  • ZEPHYRxcoreTechnology or Integration · 19 September 2022RxCap partnered with ZEPHYRx LLC, a remote respiratory monitoring solutions provider, to integrate the ZEPHYRx cloud spirometry platform with RxCap's remote monitoring platform. With this partnership, RxCap's enterprise customers can monitor the lung function of their patients with serious pulmonary conditions. The combination enables medication adherence data from RxCap's devices combined with real-time pulmonary function test data from ZEPHYRx to improve patient outcomes.
  • MedisticscoreStrategic or Co-development Partner · 1 March 2022Medistics LLC, a New Jersey-based care management company, partnered with RxCap to provide a comprehensive Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) solution. The partnership enables Qualified Health Care Professionals (QHCPs) to offer reimbursable services by utilizing existing RPM/RTM programs for their patients, providing more personalized and proactive care.
  • EpiccoreTechnology or Integration · 4 May 2021RxCap achieved certification and availability of their prescription adherence platform within the Epic App Orchard. The integration enables doctors and clinicians to access real-time medication adherence data directly within Epic EMR workflows at the point of care, within seconds. Clinicians can also access additional medication handling information like humidity and temperature data through RxCap's portal directly integrated with Epic.
  • First Databank (FDB)coreTechnology or Integration · 20 October 2020First Databank (FDB), the leading provider of drug and medical device knowledge, partnered with RxCap to release a patient-facing mobile app (RxCap Adhere) that allows patients to import personalized medication instructions from FDB Meducation. The app includes medication reminders, adherence confirmation, and access to educational materials written at 5th- to 8th-grade reading level.
  • OMRON HealthcarecoreTechnology or Integration · 6 January 2020OMRON Healthcare partnered with RxCap to integrate smart medication caps with OMRON Connect 2.0 digital health service. Through the partnership, OMRON Connect 2.0 pairs with RxCap smart medication caps to monitor adherence and set reminders to take specific medications, fostering patient-doctor dialogue and providing personalized insights.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

RxCap competitors and assessment

Company assessment

Direct peers

  • AdhereTech: AdhereTech makes connected smart pill bottles that automatically track medication adherence and send real-time reminders, directly overlapping with RxCap's smart cap and adherence device portfolio for pharma and health system customers.
  • Medisafe: Medisafe is a digital medication adherence platform combining a patient app, reminders, and analytics for pharma and health plans — directly comparable to RxCap's patient-facing app and adherence analytics stack.
  • eTectRx: eTectRx produces the ID-Cap system, a smart cap with embedded ingestible event marker that confirms actual medication ingestion — a close technical peer to RxCap's smart cap adherence technology.
  • MedMinder: MedMinder provides connected pill dispensers with cellular connectivity and adherence reminders for pharmacies, patients, and caregivers — competing in the same pharmacy-channel smart adherence category as RxCap.
  • Spencer Health Solutions: Spencer Health Solutions offers a connected medication dispensing and adherence platform with integrated RPM, serving pharma, payers, and providers with a comparable hardware-plus-software model to RxCap.
  • Hero Health: Hero Health makes a smart pill dispenser with reminders and adherence tracking, competing in the connected medication management space where RxCap's smart pill organizer and multidose devices operate.

Emerging players

  • Propeller Health (ResMed): Propeller Health provides connected inhaler sensors and respiratory adherence platforms, overlapping with RxCap's adherence + physiological device integration strategy in chronic respiratory care.

Broad incumbents

  • Vivify Health: Vivify Health is an established RPM/RTM platform serving health systems and payers with broader remote care workflows, competing with RxCap on the enterprise RTM billing side.
  • Health Recovery Solutions (HRS): HRS provides RPM kits, software, and clinical workflow tools for hospitals and home health agencies, offering a broader RPM alternative to RxCap's adherence-focused platform.
  • Caregility: Caregility is a broader virtual care and RPM platform serving health systems, with adjacent adherence and remote monitoring capabilities that overlap RxCap's enterprise RPM/RTM positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

RxCap financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RxCap leadership team

Management profile

Number of profiles

Profiles5 records

RxCap funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RxCap M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RxCap

What does RxCap do?

RxCap designs, manufactures, and sells proprietary cellular LTE-connected medication adherence hardware (smart caps, weekly pill organizers, and multidose packaging devices) and pairs them with cloud-based software, patient-facing portal and mobile apps, and an API library. The platform enables healthcare enterprises to capture real-time medication adherence events and run reimbursable Remote Therapeutic Monitoring (RTM) and Remote Patient Monitoring (RPM) programs.

Is RxCap a public or private company?

RxCap is a private company. It is classified as venture growth investor backed and is currently operating.

When was RxCap founded?

RxCap was founded in 2015. It employs 11 to 50 people.

Where is RxCap based?

RxCap is headquartered in Boston, United States, in the North America region.

How does RxCap make money?

Four revenue lines are on record. Connected Device Sales are the primary driver. The others are software Platform and API Access, channel Distribution (Centor/Gerresheimer) and strategic Partnership Solutions.

Who are RxCap's main competitors?

Direct peers on record are AdhereTech, Medisafe, eTectRx, MedMinder, Spencer Health Solutions and Hero Health. Propeller Health (ResMed) is listed as an emerging player. Broad incumbents are Vivify Health, Health Recovery Solutions (HRS) and Caregility.

Does RxCap have an API?

Yes. API library to support wide range of remote monitoring use cases and patient journeys. RxCap provides an open-architecture, full stack solution that enables ecosystem partners to quickly launch efficient remote care services with complete clinical context for medication, biometrics, and physiological data.

What industry is RxCap in?

RxCap's product category is Medication Adherence Devices. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLACAKAF, Medication Adherence, Reminders & Patient Support. Its NAICS code is 541511 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comAdherence Packaging Market to Reach USD 2.1 Billion by 2035 as Smart Medication Compliance Solutions Gain MomentumThe global adherence packaging market is projected to reach USD 2.1 billion by 2035, driven by the growth of digital health technologies, aging populations, and chronic disease prevalence. Companies like Gerresheimer AG and RxCap have introduced connected medication monitoring solutions in the market.RxcapWysa Partners with RxCap to Advance Medication AdherenceWysa has announced a strategic partnership with RxCap to integrate RxCap’s remote monitoring technology into Wysa’s behavioral health care platform. This collaboration allows healthcare providers to monitor medication adherence in real-time, identify non-adherence issues, and deliver timely interventions to improve patient outcomes. The integrated solution is set to roll out to select provider organizations starting in July 2025.PR NewswireCentor Launches Smart Pill Organizer to Support Medication AdherenceCentor Inc., a subsidiary of Gerresheimer, launched a new smart weekly pill organizer in partnership with RxCap to support medication adherence through real-time LTE data transmission. The device allows pharmacies and clinical partners to monitor patient intake without requiring app installation, aiming to improve therapy outcomes and prevent hospitalizations. This turnkey solution is now available for U.S. pharmacies via Centor's remote monitoring service.GerresheimerCentor Launches Smart Pill Organizer to Support Medication AdherenceCentor Inc., a subsidiary of Gerresheimer, has launched a new smart weekly pill organizer in collaboration with RxCap to support medication adherence for patients in the US. The connected device uses LTE signals and cloud technology to monitor medication intake in real-time without requiring patients to install an app, allowing pharmacies to provide remote monitoring services. This product expands Centor's portfolio of remote care solutions aimed at improving therapy outcomes and preventing hospitalizations.SecSEC FORM DRxCap, Inc. filed a Form D with the Securities and Exchange Commission to report an exempt securities offering under Regulation D Rule 506(b). The company disclosed a total offering amount of approximately $21.1 million, of which roughly $19.7 million has been sold to 22 investors.SecSEC FORM DRxCap, Inc. filed a Form D with the Securities and Exchange Commission to report an exempt offering of securities under Rule 506(b). The filing indicates that out of a total offering amount of $21,156,047, approximately $19.6 million has been sold to 22 investors as of April 25, 2024. The remaining balance of roughly $1.5 million is still available for sale.PR NewswireGerresheimer partners with RxCap to offer connected adherence solutionsGerresheimer has entered into a partnership with US digital health company RxCap and acquired a minority stake in the company. Through its subsidiary Centor, the German pharma packaging company will hold exclusive distribution rights in the U.S. for RxCap's connected prescription vial closure devices and cloud-based medication adherence monitoring software. The partnership enables pharmacies to offer remote therapeutic monitoring solutions that track when patients take their medication, creating new revenue streams while improving patient health outcomes.MorningstarGerresheimer partners with RxCap to offer connected adherence solutionsGerresheimer's subsidiary Centor will receive exclusive U.S. pharmacy distribution rights for RxCap's connected prescription vial closure devices and cloud-based adherence software. Gerresheimer also acquired a minority stake in RxCap and appointed a board representative. The partnership aims to expand Centor's product offering and create recurring revenue streams.Business InsiderGerresheimer In Deal With RxCap To Offer Connected Adherence Solutions; Buys Minority StakeGerresheimer AG announced a partnership with RxCap, acquiring a minority stake and granting its Centor unit exclusive U.S. pharmacy distribution rights for RxCap's connected adherence solutions. The deal includes prescription vial closure devices and cloud-based software, available for U.S. pharmacies. Gerresheimer will appoint a representative to RxCap's board.GerresheimerGerresheimer partners with RxCap to offer connected adherence solutionsGerresheimer announced on April 29, 2024 a partnership with Boston-based digital health company RxCap, acquiring a minority stake and appointing a representative to RxCap's Board of Directors. Gerresheimer's US subsidiary Centor receives exclusive distribution rights for RxCap's connected prescription vial closure devices and cloud-based adherence software to US pharmacies. Financial terms were not disclosed.